Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease

Fig. 4

Immunohistochemistry and quantitative analysis for anti-CD68 and anti-α-SMA. Anti-CD68 for the a CKD group, b RPC group, and c hiPSC group, magnification of × 40. d Anti-CD68 quantitative analysis for all the three groups. Anti-α-SMA for the e CKD group, f RPC group, and g hiPSC group, magnification of × 40. h Anti-α-SMA quantitative analysis for all the three groups. *p value < 0.05 vs. CKD

Back to article page